Zydus Cadila gets DCGI nod for launch of its NCE for diabetes

Cadila Healthcare today said Indian drug regulator has approved its new chemical entity, Lipaglyn to be used for treating a type of diabetes for launch in the country.

No proposal to introduce new TB drug: Govt

There is no proposal to introduce Tuberculosis drug Bedaquiline in the Indian market, parliament was told Tuesday.

Panel finds irregularities in drugs approval, seeks review

Government panel found irregularities in approval of 38 drugs without clinical trials on Indians saying exemptions "appear to be due to pressure from pharma companies".

Govt likely to ban OTC sale of 91 drugs

Amid concerns over rampant use of antibiotics and resistance developed towards them, government is set to restrict over-the-counter sale of 91 such new generation drugs through a notification which is likely soon.

Clinical trial process to be further streamlined: Govt

Procedures for clinical trials in India will be further streamlined and a panel of experts set up to analyse the cause of injury or death and to recommend quantum of compensation to victims, the Government today said.

Controller clears clot-buster drug for human trial

The Drug Controller General of India has cleared a bio-therapeutic clot-buster drug for phase-one human clinical trials, a statement said Friday.

`Priorities of Drugs Control Organisation skewed`

A Parliamentary panel held CDSCO responsible for most ills besetting the drugs regulation in the country.

Bar-coding a must to check counterfeit drugs: DCGI

The pharmaceutical industry to adopt bar-coding system to track and trace origin of drugs.

Approval for VLP technology vaccine will take some time: DCGI

Drug controller general of India (DGCI) which was cautious in giving nod to the new virus like particle (VLP) technology for developing H1N1 vaccine earlier this year, says the vaccine will get an approval.

Approval for VLP technology vaccine will take some time: DCGI

Drug controller general of India (DGCI) which was cautious in giving nod to the new virus like particle (VLP) technology for developing H1N1 vaccine earlier this year, says the vaccine will get an approval.

Clinical trial inspections to begin in India

CDSCO says that inspection of clinical trials in routine course across
India will begin soon.

Clinical trial inspections to begin in India

CDSCO says that inspection of clinical trials in routine course across
India will begin soon.

DCGI mulls to introduce mobile drug testing vans

DGCI says about 40,000 drug samples from across country are collected for verification.

DCGI mulls to introduce mobile drug testing vans

DGCI says about 40,000 drug samples from across country are collected for verification.

DCGI asks GSK to withdraw promotional advertisement

National health regulator Drug Controller General of India (DCGI) has asked drug maker GSK to withdraw promotional advertisement for cervical cancer vaccine, after it found the campaign to be violating certain norms.